politics
Court rules companies can't import Gilead medications from overseas in blow to AFP health programs
A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.
TL;DR
- U.S. appeals court ruled in favor of Gilead Sciences.
- Alternative funding programs that import medicines from overseas were the subject of the ruling.
- The court's decision prevents the import of medicines by these programs.